- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Carfilzomib, Thalidomide and Dexamethasone
Total 3975 results
-
National University Hospital, SingaporeCelgene; International Myeloma Foundation; The Australasian Leukaemia & Lymphoma...UnknownRelapsed and/or Refractory Multiple MyelomaSingapore, Hong Kong, Korea, Republic of, Taiwan
-
University College, LondonCompleted
-
Grupo de Estudos Multicentricos em Onco-HematologiaUnknown
-
Henrik GregersenNordic Myeloma Study GroupUnknownMultiple MyelomaFinland, Denmark, Sweden, Norway, Lithuania
-
University of LeedsMerck Sharp & Dohme LLC; Celgene; AmgenUnknown
-
PETHEMA FoundationCompleted
-
IRCCS Burlo GarofoloUniversity of Pisa; University of Trieste; University of Messina; Università degli... and other collaboratorsCompletedInflammatory Bowel Diseases | Crohn's Disease | Ulcerative ColitisItaly
-
Janssen Research & Development, LLCTerminatedMultiple MyelomaCanada, United States, Belgium, Poland, Italy, France, Spain, Brazil, Russian Federation, Denmark, Greece, Germany, Netherlands
-
AmgenCompletedHepatic Impairment | Solid Tumors | Hematologic MalignanciesUnited Kingdom, Netherlands, United States, France
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
Oslo University HospitalUniversity Hospital of North Norway; Helse Stavanger HF; Haukeland University... and other collaboratorsRecruiting
-
Central Hospital, Nancy, FranceNot yet recruiting
-
European Myeloma NetworkSanofi; Amgen; EMN Research ItalyActive, not recruitingMultiple MyelomaCzechia, Germany, Greece, Italy, Netherlands, Norway, Spain
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
Universitätsklinikum Hamburg-EppendorfGemeinsamer Bundesausschuss (G-BA); Staburo GmbHRecruiting
-
AmgenCompletedMultiple MyelomaCanada, Denmark, Finland, France, Italy, Spain, Sweden, United Kingdom, Czechia, Poland, United States, Belgium, Hungary, New Zealand, Australia, Germany, Japan, Greece, Norway, Romania
-
Intergroupe Francophone du MyelomeJanssen Research & Development, LLC; HOVON - Dutch Haemato-Oncology AssociationActive, not recruitingMultiple MyelomaNetherlands, France, Belgium
-
Hackensack Meridian HealthActive, not recruitingMultiple MyelomaUnited States
-
University of NebraskaM.D. Anderson Cancer CenterTerminatedCabozantinib as a Targeted Strategy to Reverse Carfilzomib Resistance in Refractory Multiple MyelomaMultiple Myeloma | Refractory Multiple Myeloma | Relapsed/Refractory Multiple MyelomaUnited States
-
Celgene CorporationCompletedMultiple MyelomaUnited States, Spain, Australia, Canada, United Kingdom, Italy, Switzerland, Bulgaria, Poland, Ukraine, Belgium, Germany, Hungary, Ireland, Israel, Russian Federation
-
Intergroupe Francophone du MyelomeUnknown
-
Hackensack Meridian HealthSuspendedMultiple MyelomaUnited States
-
OncotherapeuticsAmgenUnknownMultiple MyelomaUnited States
-
Mayo ClinicCompletedMultiple Myeloma | Stage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States
-
Children's Hospital Medical Center, CincinnatiBill and Melinda Gates Foundation; Syngene InternationalCompleted
-
Arbeitsgemeinschaft medikamentoese TumortherapieAmgenCompletedMultiple MyelomaAustria, Germany
-
University Hospital, CaenLaphalCompleted
-
SCRI Development Innovations, LLCAmgenCompletedNeuroendocrine CancerUnited States
-
John F. McDyer, MDCompletedLung Transplant RejectionUnited States
-
Seoul National University Bundang HospitalCompletedEvaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or BetamethasoneBack Pain | Neck PainKorea, Republic of
-
University of OklahomaStony Brook UniversityCompletedIntraventricular Hemorrhage | Respiratory Distress Syndrome | Neonatal MortalityUnited States
-
Ahmadu Bello University Teaching HospitalCompletedNeonatal Respiratory Distress SyndromeNigeria
-
Weill Medical College of Cornell UniversityCelgeneTerminated
-
Southwest Oncology GroupNational Cancer Institute (NCI)TerminatedMultiple MyelomaUnited States
-
SanofiActive, not recruitingPlasma Cell MyelomaFrance, United States, Australia, Brazil, Canada, Czechia, Greece, Hungary, Italy, Japan, Korea, Republic of, New Zealand, Russian Federation, Spain, Turkey, United Kingdom
-
University of ArkansasTerminatedMultiple MyelomaUnited States
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
OncotherapeuticsAmgenCompletedMultiple MyelomaUnited States
-
Spectrum Health HospitalsCompletedMultiple MyelomaUnited States
-
Grupo de Estudos Multicentricos em Onco-HematologiaCompleted
-
University of ArkansasCompleted
-
University of Maryland, BaltimoreNational Cancer Institute (NCI); University of Maryland Greenebaum Cancer CenterCompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
Second Military Medical UniversityXiangya Hospital of Central South University; Peking University People's Hospital and other collaboratorsUnknown
-
Gleneagles HospitalSamsung Medical Center; Asan Medical Center; Chonnam National University Hospital and other collaboratorsCompletedMultiple MyelomaKorea, Republic of, Singapore, India
-
Sheba Medical CenterUnknown
-
SanofiRecruitingRelapsed/Refractory Multiple MyelomaCzechia, Japan, Australia, Brazil, Greece, Portugal
-
Peking University First HospitalRecruitingMultiple Myeloma | Renal InjuryChina
-
China Medical University, ChinaGeneral Hospital of Shenyang Military Region; Shengjing Hospital; Liaoning Tumor... and other collaboratorsCompleted
-
University Health Network, TorontoCelgene CorporationCompleted